Drug Profile
Vemurafenib companion diagnostic - Roche
Alternative Names: cobas 4800 BRAF V600 Mutation TestLatest Information Update: 15 Apr 2015
Price :
$50
*
At a glance
- Originator Roche Diagnostics
- Class Diagnostic agents
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Malignant melanoma
Most Recent Events
- 02 Dec 2014 Registered for Diagnostic tests in Japan (unspecified route)
- 02 Dec 2014 Registered for Malignant melanoma (Diagnosis) in Japan (unspecified route)
- 06 Dec 2012 Roche plans a non-interventional study for Malignant melanoma diagnosis in France (NCT01744860)